{"title":"Prevalence of suicidal thoughts and attempts in the transgender population of the world: a systematic review and meta-analysis.","authors":"Parisa Kohnepoushi, Maziar Nikouei, Mojtaba Cheraghi, Parsa Hasanabadi, Hamza Rahmani, Maryam Moradi, Ghobad Moradi, Farhad Moradpour, Yousef Moradi","doi":"10.1186/s12991-023-00460-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of this meta-analysis was to determine global pooled prevalence of suicide thoughts and attempts in transgender population.</p><p><strong>Methods: </strong>For doing comprehensive search strategy related to objectives in the presence meta-analysis, all international databases like PubMed (Medline), Scopus, Embase, Web of Sciences, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature (CINHAL) were searched from January 1990 to December 2022. The quality of the final selected studies was evaluated according to Newcastle-Ottawa Quality Assessment Scale for cross-sectional studies. The subgroup analysis was done based on type of transgender (female to male, male to female) and prevalence (point, period, and lifetime), country, and criteria of diagnosis. All analysis was done in STATA version 17.</p><p><strong>Results: </strong>From the total number of 65 selected studies, 71 prevalence of suicidal thoughts, including point, period, and lifetime prevalence were extracted and combined. After combining these values, the prevalence of suicidal thoughts in the transgender population in the world was 39% in the past month (pooled point prevalence: 39%; 95% CI 35-43%), 45% in the past year (pooled period prevalence: 45%; % 95 CI 35-54%) and 50% during lifetime (pooled lifetime prevalence: 50%; % 95 CI 42-57%). Also, the prevalence of suicide attempt in the transgender population of the world was 16% in the past month (pooled point prevalence: 16%; 95% CI 13-19%), 11% in the past year (pooled period prevalence: 11%; % 95 CI 5-19%) and 29% during lifetime (pooled lifetime prevalence: 29%; % 95 CI 25-34%).</p><p><strong>Conclusion: </strong>The present meta-analysis results showed the prevalence of suicidal thoughts and attempts in the transgender community was high, and more importantly, about 50% of transgenders who had suicidal thoughts, committed suicide.</p>","PeriodicalId":7942,"journal":{"name":"Annals of General Psychiatry","volume":"22 1","pages":"28"},"PeriodicalIF":3.6000,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403892/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of General Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12991-023-00460-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The aim of this meta-analysis was to determine global pooled prevalence of suicide thoughts and attempts in transgender population.
Methods: For doing comprehensive search strategy related to objectives in the presence meta-analysis, all international databases like PubMed (Medline), Scopus, Embase, Web of Sciences, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature (CINHAL) were searched from January 1990 to December 2022. The quality of the final selected studies was evaluated according to Newcastle-Ottawa Quality Assessment Scale for cross-sectional studies. The subgroup analysis was done based on type of transgender (female to male, male to female) and prevalence (point, period, and lifetime), country, and criteria of diagnosis. All analysis was done in STATA version 17.
Results: From the total number of 65 selected studies, 71 prevalence of suicidal thoughts, including point, period, and lifetime prevalence were extracted and combined. After combining these values, the prevalence of suicidal thoughts in the transgender population in the world was 39% in the past month (pooled point prevalence: 39%; 95% CI 35-43%), 45% in the past year (pooled period prevalence: 45%; % 95 CI 35-54%) and 50% during lifetime (pooled lifetime prevalence: 50%; % 95 CI 42-57%). Also, the prevalence of suicide attempt in the transgender population of the world was 16% in the past month (pooled point prevalence: 16%; 95% CI 13-19%), 11% in the past year (pooled period prevalence: 11%; % 95 CI 5-19%) and 29% during lifetime (pooled lifetime prevalence: 29%; % 95 CI 25-34%).
Conclusion: The present meta-analysis results showed the prevalence of suicidal thoughts and attempts in the transgender community was high, and more importantly, about 50% of transgenders who had suicidal thoughts, committed suicide.
背景:本荟萃分析的目的是确定全球跨性别人群中自杀念头和企图的总体流行率。方法:检索1990年1月至2022年12月的PubMed (Medline)、Scopus、Embase、Web of Sciences、PsycINFO、care and Allied Health Literature Cumulative Index (CINHAL)等国际数据库,针对存在meta分析的目标进行综合检索策略。根据纽卡斯尔-渥太华横断面研究质量评估量表评估最终入选研究的质量。亚组分析是根据跨性别类型(女变男、男变女)、患病率(时间点、时间和寿命)、国家和诊断标准进行的。所有的分析都在STATA版本17中完成。结果:从选取的65项研究中,提取并合并了71项自杀念头患病率,包括自杀点、自杀期和自杀终生患病率。综合这些值,过去一个月全球跨性别人群中自杀念头的患病率为39%(汇总点患病率:39%;95% CI 35-43%),过去一年为45%(合并期患病率:45%;% 95 CI 35-54%)和50%的终生患病率(终生总患病率:50%;% 95 ci 42-57%)。此外,在过去的一个月里,全球跨性别人群的自杀未遂率为16%(汇总点患病率:16%;95% CI 13-19%),过去一年为11%(合并期患病率:11%;% 95 CI 5-19%)和29%(终生总患病率:29%;% 95 ci 25-34%)。结论:本荟萃分析结果显示,跨性别群体中自杀念头和企图的患病率较高,更重要的是,有自杀念头的跨性别者中约有50%的人自杀。
期刊介绍:
Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.
Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.